Apparently, circulation levels of adipokines such as leptin and adiponectin can act as biomarkers to evaluate obesity-associated complications, including low-grade inflammation [48]. The gene discussed is ADIPOQ; the disease is obesity due to melanocortin 4 receptor deficiency.